Delivery Order SPE2D021D0008-SPE2D324F9821
- Not listed
- This federal contract award to American Regent Inc. is for the delivery of atropine sulfate injection, a critical care medication, to support military medical treatment facilities worldwide. The award, valued at $1,852.50, was made by the Defense Logistics Agency (DLA) Troop Support Medical and is a firm-fixed-price delivery order contract. American Regent Inc. is a pharmaceutical manufacturer and distributor that specializes in injectable drugs and sterile pharmaceutical preparations. The...
- This federal contract award, identified as SPE2D021D0008|SPE2D324F185K, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor, American Regent Inc. The contract is for the delivery of atropine sulfate injection, a critical care medication used in emergency situations. The award is a firm-fixed-price delivery order with a ceiling value of $1,852.50 and an ultimate completion date of August 13, 2024. American Regent Inc. is a pharmaceutical manufacturer and...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to American Regent Inc., a pharmaceutical manufacturer and distributor, for the supply of atropine sulfate injection. The contract, valued at $1,852.50, is a firm-fixed-price delivery order with a period of performance ending on July 11, 2024. American Regent Inc. holds multiple federal contract vehicles, including a $131.4 million Federal Supply Schedule contract with the Department of Veterans...
- This is a firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to American Regent Inc., a subsidiary of Daiichi Sankyo Group. The $2,778.75 order is for the delivery of atropine sulfate injection, a critical care pharmaceutical product, to support the DLA's mission of maintaining medical readiness for the U.S. armed forces. American Regent Inc. has been awarded numerous prime federal contracts, primarily delivery orders, to provide essential medical...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a $1,111.45 firm-fixed-price delivery order to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Atropine Sulfate Injection. This order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 through December 2025, which enables the DLA to efficiently procure a comprehensive range of medical commodities to support military treatment programs and facilities worldwide....
- This federal contract award, valued at $9,116.78, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of Atropine 1 mg/ml vials, a medication used to treat certain medical conditions. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00, which Amerisourcebergen Drug Corp holds with the DLA Troop Support...
- This federal contract award is for the delivery of ATROPINE 0.4 MG/ML injectable medication to the Defense Logistics Agency (DLA) Troop Support Medical, a division of the Department of Defense (DoD). The $5,920.62 firm-fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. This award is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Cencora, Inc. holds with the DLA Troop Support Medical,...
- This federal contract award, valued at $1,373.21, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of 4565072470 - Atropine Sulfate Injection, 1 mL, a critical pharmaceutical product. The contract has a firm fixed price and a completion date of July 5, 2024. Amerisourcebergen Drug Corp is a major supplier of pharmaceutical products and medical supplies to the U.S. federal...
- This federal contract award, valued at $2,829.90, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999, which serves as a primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract covers critical...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The $5,354.20 firm fixed-price delivery order is for the supply of ATROPINE 8 MG/20 ML VIAL 20ML medical products. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
- SPE2D021D0008Indefinite Delivery Contract
- SPE2D021D0008-SPE2D324F9821Delivery Order
This federal contract award, valued at $28,713.75, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to American Regent Inc., a pharmaceutical manufacturer and distributor. The contract is for the delivery of atropine sulfate injection, a critical care medication, to support military healthcare programs and maintain medical readiness for the armed forces. The award is a firm fixed-price delivery order against an existing indefinite delivery, indefinite quantity (IDIQ) contract held by American Regent Inc. with the DLA Troop Support Medical. The company has a $13.8 million IDIQ contract with the agency to provide various pharmaceuticals, including atropine, glycopyrrolate, and hydroxyzine, to military medical treatment facilities worldwide through September 2031. This specific delivery order has an ultimate completion date of May 21, 2024. The contract does not have a set-aside designation.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $28.7k | 5/16/24 |